These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17183568)

  • 1. The clinical aspects of newborn screening: importance of newborn screening follow-up.
    James PM; Levy HL
    Ment Retard Dev Disabil Res Rev; 2006; 12(4):246-54. PubMed ID: 17183568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New challenges to the Screening Center in the Bavarian State office for Health Care and Safe Quality of Foods].
    Nennstiel-Ratzel U; Arenz S; Wildner M; Kries RV; Liebl B
    Gesundheitswesen; 2004 Feb; 66 Suppl 1():S8-12. PubMed ID: 14770331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
    Bishop Hubbard H
    Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded newborn screening: information and resources for the family physician.
    Waisbren SE
    Am Fam Physician; 2008 Apr; 77(7):987-94. PubMed ID: 18441864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening: an overview.
    Carreiro-Lewandowski E
    Clin Lab Sci; 2002; 15(4):229-38. PubMed ID: 12776783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded newborn screening for genetic and metabolic disorders: modeling costs and outcomes.
    Hubbard HB
    Nurs Econ; 2007; 25(6):345-52. PubMed ID: 18240836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.
    Wilcken B; Haas M; Joy P; Wiley V; Bowling F; Carpenter K; Christodoulou J; Cowley D; Ellaway C; Fletcher J; Kirk EP; Lewis B; McGill J; Peters H; Pitt J; Ranieri E; Yaplito-Lee J; Boneh A
    Pediatrics; 2009 Aug; 124(2):e241-8. PubMed ID: 19620191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of expanded newborn screening--United States, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(37):1012-5. PubMed ID: 18802410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects.
    Garg U; Dasouki M
    Clin Biochem; 2006 Apr; 39(4):315-32. PubMed ID: 16563365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation and emergency management of inborn errors of metabolism presenting in the newborn.
    Christodoulou J
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():189-97. PubMed ID: 15906734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The failure to diagnose inborn errors of metabolism in New Zealand: the case for expanded newborn screening.
    Wilson C; Kerruish NJ; Wilcken B; Wiltshire E; Webster D
    N Z Med J; 2007 Sep; 120(1262):U2727. PubMed ID: 17891215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report.
    Yoon HR; Lee KR; Kang S; Lee DH; Yoo HW; Min WK; Cho DH; Shin SM; Kim J; Song J; Yoon HJ; Seo S; Hahn SH
    Clin Chim Acta; 2005 Apr; 354(1-2):167-80. PubMed ID: 15748614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2012 Apr; 61(RR-2):1-44. PubMed ID: 22475884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening.
    Sahai I; Marsden D
    Crit Rev Clin Lab Sci; 2009; 46(2):55-82. PubMed ID: 19255915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical approach to the diagnoses of inborn errors of metabolism.
    Kamboj M
    Pediatr Clin North Am; 2008 Oct; 55(5):1113-27, viii. PubMed ID: 18929055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic screening in the NICU population: a proposal for change.
    Strobel SE; Keller CS
    Pediatr Nurs; 1993; 19(2):113-7. PubMed ID: 8502492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for metabolic disorders.
    Marsden D; Larson C; Levy HL
    J Pediatr; 2006 May; 148(5):577-584. PubMed ID: 16737864
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland--experience and development of a routine program for expanded newborn screening.
    Lund AM; Hougaard DM; Simonsen H; Andresen BS; Christensen M; Dunø M; Skogstrand K; Olsen RK; Jensen UG; Cohen A; Larsen N; Saugmann-Jensen P; Gregersen N; Brandt NJ; Christensen E; Skovby F; Nørgaard-Pedersen B
    Mol Genet Metab; 2012 Nov; 107(3):281-93. PubMed ID: 22795865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A primer on expanded newborn screening by tandem mass spectrometry.
    McCandless SE
    Prim Care; 2004 Sep; 31(3):583-604, ix-x. PubMed ID: 15331249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.